Chemotherapy
Clinical Reports
Piperacillin in the Treatment of Urinary Tract InfectionsSander S. · Bergan T. · Fossberg E.Department of Surgery and Department of Bacteriology, Aker Hospital, University of Oslo, Oslo
Keywords: PiperacillinUrinary tract infections |
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: September 08, 2009
Issue release date: 1980
Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 0
ISSN: 0009-3157 (Print)
eISSN: 1421-9794 (Online)
For additional information: https://www.karger.com/CHE
Abstract
The ureidopenicillin piperacillin was given to 20 patients with urinary tract infections. The infecting microbes all had a minimum inhibitory concentration below 0.6 μg/ml. One strain of Staphylococcus aureus produced β-lactamase. All patients were freed of their microbes at the end of 7 days therapy. 1-2 weeks after the end of therapy, 1 relapsed and 3 had superinfections. Among the 16 who were without bacteria or leucocyturia after 1-2 weeks, 2 exhibited a superinfection 4-6 weeks after the end of therapy.
© 1980 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Published online: September 08, 2009
Issue release date: 1980
Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 0
ISSN: 0009-3157 (Print)
eISSN: 1421-9794 (Online)
For additional information: https://www.karger.com/CHE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission